🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Amberjack Capital Partners

2 posts
Innovex International’s 5 million-share secondary offering by Amberjack Capital Partners puts fresh share supply in focus after the recent INVX rally, even as the company itself receives no proceeds from the sale. Representative image.
Read More

No dilution, no new cash, but Innovex International’s latest offering could still reshape the INVX story

Innovex International will receive no proceeds from Amberjack Capital Partners’ latest 5 million-share secondary offering, but the size of the block, its timing after strong second-quarter results and its potential impact on Amberjack’s ownership make the transaction more consequential than a routine shareholder sale.